Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Short Interest Down 6.3% in November
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) saw a large decline in short interest in November. As of November 15th, there was short interest totalling 6,500,000 shares, a decline of 6.3% from the October 31st total of 6,940,000 shares. Based on an average daily trading volume, of 713,900 shares, the days-to-cover ratio is presently […]
More Stories
StockNews.com Initiates Coverage on Fuel Tech (NASDAQ:FTEK)
StockNews.com initiated coverage on shares of Fuel Tech (NASDAQ:FTEK – Free Report) in a research report released on Wednesday morning....
Remark (NASDAQ:MARK) Earns Sell Rating from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Remark (NASDAQ:MARK – Free Report) in a report published on Wednesday morning. The firm...
Avinger (NASDAQ:AVGR) Now Covered by Analysts at StockNews.com
StockNews.com initiated coverage on shares of Avinger (NASDAQ:AVGR – Free Report) in a research note released on Wednesday. The brokerage...
Cytosorbents (NASDAQ:CTSO) Earns Hold Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of Cytosorbents (NASDAQ:CTSO – Free Report) in a research note issued to investors on Wednesday...
comScore (NASDAQ:SCOR) Earns Buy Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of comScore (NASDAQ:SCOR – Free Report) in a report issued on Wednesday. The brokerage issued...
Ohio Valley Banc (NASDAQ:OVBC) Earns Hold Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of Ohio Valley Banc (NASDAQ:OVBC – Free Report) in a research report sent to investors...